Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|June 25, 2020
Galectins in the Tumor Microenvironment: Focus on Galectin-1Neus Martínez-Bosch, Pilar Navarro
Oncoimmunology|January 23, 2015
Targeting Galectin-1 in pancreatic cancer: immune surveillance on guardNeus Martínez-Bosch, Pilar Navarro
Methods in Molecular Biology (Clifton, N.J.)|March 23, 2022
Exploring the Role of Galectins in Cancer : In Vitro and In Vivo ApproachesNeus Martínez-Bosch, Noemí Manero-Rupérez, Mireia Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2020
Impact of Galectins in Resistance to Anticancer TherapiesPilar Navarro, Neus Martínez-Bosch, Ada G Blidner, et al.
The American Journal of Pathology|December 22, 2015
Poly(ADP-Ribose) Polymerases: New Players in the Pathogenesis of Exocrine Pancreatic DiseasesNeus Martínez-Bosch, Martin E Fernández-Zapico, Pilar Navarro, et al.
Ebiomedicine|August 13, 2024
Hallmarks of pancreatic cancer: spotlight on TAM receptorsNúria Vázquez-Bellón, Neus Martínez-Bosch, Pablo García de Frutos, et al.
Cells|March 15, 2020
The Galectin Family as Molecular Targets: Hopes for Defeating Pancreatic CancerNoemí Manero-Rupérez, Neus Martínez-Bosch, Luis E Barranco, et al.
APL Bioengineering|March 31, 2025
Quantitative characterization of the 3D self-organization of PDAC tumor spheroids reveals cell type and matrix dependence through advanced microscopy analysisSoraya Hernández-Hatibi, Carlos Borau, Neus Martínez-Bosch, et al.
Nature Reviews. Urology|April 25, 2019
Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunitiesNeus Martínez-Bosch, Alejo Rodriguez-Vida, Núria Juanpere, et al.
The Journal of Pathology|June 4, 2014
Parp-1 genetic ablation in Ela-myc mice unveils novel roles for Parp-1 in pancreatic cancerNeus Martínez-Bosch, Mar Iglesias, Jessica Munné-Collado, et al.
Pageof 3